Fig. 3.
The presence of single or double GST deletions in patients with intermediate-risk karyotype is associated with poor outcome.
Patients were grouped according to cytogenetics and their overall survival curves according to GST− status are shown.GSTM1− and GSTT1−indicate patients with GSTM1 and GSTT1 deletions, whereas GSTM1+/GSTT1+ indicates patients with undeleted GST genotype.